William Benton Jones's most recent trade in Corvus Pharmaceuticals Inc was a trade of 19,357 Common Stock done at an average price of $3.5 . Disclosure was reported to the exchange on June 4, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Corvus Pharmaceuticals Inc | William Benton Jones | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.50 per share. | 04 Jun 2025 | 19,357 | 173,130 (0%) | 0% | 3.5 | 67,750 | Common Stock |
| Corvus Pharmaceuticals Inc | William Benton Jones | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Jun 2025 | 19,357 | 0 | - | - | Warrant (Right to Buy) | |
| Corvus Pharmaceuticals Inc | Jones William Benton | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Dec 2024 | 300,000 | 300,000 | - | - | Stock Option (Right to Buy) | |
| Corvus Pharmaceuticals Inc | William Benton Jones | See Remarks | Purchase of securities on an exchange or from another person at price $ 1.73 per share. | 06 May 2024 | 20,000 | 153,773 (0%) | 0% | 1.7 | 34,624 | Common Stock |
| Corvus Pharmaceuticals Inc | William Benton Jones | See Remarks | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 06 May 2024 | 19,357 | 19,357 | - | - | Warrant (Right to Buy) | |
| Corvus Pharmaceuticals Inc | William Benton Jones | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Dec 2023 | 200,000 | 200,000 | - | - | Stock Option (Right to Buy) | |
| Corvus Pharmaceuticals Inc | William Benton Jones | See Remarks | Purchase of securities on an exchange or from another person at price $ 0.79 per share. | 20 Dec 2022 | 20,000 | 133,773 (0%) | 0% | 0.8 | 15,800 | Common Stock |
| Corvus Pharmaceuticals Inc | William Benton Jones | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Aug 2022 | 160,000 | 160,000 | - | - | Stock Option (Right to Buy) | |
| Corvus Pharmaceuticals Inc | William Benton Jones | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Sep 2021 | 160,000 | 160,000 | - | - | Stock Option (Right to Buy) | |
| Corvus Pharmaceuticals Inc | William Benton Jones | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Dec 2020 | 160,000 | 160,000 | - | - | Stock Option (Right to Buy) |